Methods
Modeling the initial structures
The X-ray crystal structure of MMP-2 complexes with APP-derived decapeptide inhibitor (APP-IP) having ISYGNDALMP sequence (PDB code 3AYU) was retrieved from the Protein Data Bank (www.pdb.org). To prepare for the docking experiment, the PDB files were modified by Build Module of Discovery Studio (DS) version 2.5 developed by Accelrys. The active site was defined as all the amino acid residues enclosed within a 6.5 Å radius sphere centered by the bound inhibitor, APP-IP. To extract ligand from the complex in the PDB file, hydrogen atoms were added to the enzymes under the condition of pH 7.5, which corresponded to the environmentalconditions. Hereafter, to release any internal strain in the crystal structure, we fixed the secondary structure and performed an energy minimization of 300 steps of conjugate gradient with a convergence value of 0.05 kcal mol -1 Å -1 , in which explicit periodic boundary conditions (PBCs) was used and 7 Å from any face of a water layer box was added to MMP-2.
All energy minimizations were performed using CHARMm force field parameters.
Docking of MMP-P12 into MMP-2
The molecular docking was carried out with Protein Docking Module of DS ( Figure E3 , and Asn 147 in MMP-2) were allowed to move during docking. Three dimensional structures of MMP-P12, built using the Fragment Builder tools of DS, were minimized using a Standard Dynamic Cascade protocol.
The low-energy MMP-P12conformations were docked into the active site of the MMP-2 model using ZDOCK (Table E1 ). The energy minimization of the resultant conformation by ZDOCK was then performed using RDOCK with CHARMM force field parameters (Table E2) . DS also offered powerful analysis tools of ZRANK, including cluster analysis, to help users to easily and quickly narrow the scope of the ZDOCK structure, locking the structure of the complexes of interest.
Stability test
1 mL of RPMI1640 supplemented with 25% (v/v) of mouse serum was allocated into a 1.5
Eppendorf tube and temperature-equilibrated at 37C for 15 min before adding of MMP-P12.
Thereafter, 100 µL of the reaction solution was removed immediately and added into 200 µL of 96% ethanol for precipitation of serum proteins. The cloudy reaction sample is cooled at 4Cfor 15 min and centrifuged at 14, 000 rmp for 2 min to pellet the precipitated serum proteins. The reaction supernatant is then analyzed by RP-HPLC on C18 column (5 µm, 120A, 250 × 4.6 mm) using 5% to 65% acetonitrile containing 0.1% TFA versus distilled water containing 0.1% TFA over 30 minutes at a flow rate of 1mL/min. Sample after 60 and 120 minutes incubation with serum was taken out for HPLC test under the same condition as above. Blood stability test was done in a 21 day PF mouse model. After injection of MMP-P12, we collected mouse blood at different time points. Blood was centrifuged and serum was collected for LC/MS analysis. 
